JP Morgan Chase’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
UCFA
VCM
VPM
MC
JP Morgan Chase's RGEN Position: Q1 2026 in Review
JP Morgan Chase reduced its Repligen (RGEN) stake by 48% in Q1 2026, selling an estimated $16.9M and leaving 128,221 shares worth $14.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2374.
JP Morgan Chase first reported a position in RGEN in Q2 2014 and has held it in 44 quarters since. The position peaked at $98.2M in Q1 2021. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.
- JP Morgan Chase held 128,221 shares of Repligen worth $14.3M as of Q1 2026.
- JP Morgan Chase sold 120,716 Repligen shares in Q1 2026, an estimated $16.9M.
- Repligen made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #2374 holding.
- JP Morgan Chase first reported a position in Repligen in Q2 2014 and has held it in 44 quarters since.
- JP Morgan Chase's Repligen position peaked at $98.2M in Q1 2021.
- 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.
Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.